Tuesday, October 31, 2006

Spanish Court Supports Ranbaxy

A Spanish Court has favored Ranbaxy’s action for invalidation of Pfizer’s Spanish patent covering calcium salt of atorvastatin and eventually invalidate Spanish Patent ES 2,167,306 for lack of novelty. Earlier, the Mercantile Court of Barcelona had sought an advisory opinion on Spanish patent covering atorvastatin calcium from the European Patent Office, wherein EPO found them to be valid. The court delivered its decision after considering the views of Spanish Patent Office and technical expert reports.

No comments:

Post a Comment